BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31701821)

  • 1. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.
    Chichareon P; Modolo R; Kerkmeijer L; Tomaniak M; Kogame N; Takahashi K; Chang CC; Komiyama H; Moccetti T; Talwar S; Colombo A; Maillard L; Barlis P; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Mehran R; Serruys PW
    JAMA Cardiol; 2020 Jan; 5(1):21-29. PubMed ID: 31693078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
    Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2.
    Yamamoto K; Natsuaki M; Yoshikawa Y; Morimoto T; Shiomi H; Watanabe H; Kato T; Saito N; Kadota K; Ando K; Furukawa Y; Tamura T; Sakamoto H; Toyofuku M; Inada T; Inoko M; Suwa S; Onodera T; Ishii K; Kanamori N; Kimura T;
    Circ J; 2020 Sep; 84(10):1734-1745. PubMed ID: 32893236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Matsumura-Nakano Y; Nakatsuma K; Watanabe H; Yamamoto E; Kato E; Fuki M; Yamaji K; Nishikawa R; Nagao K; Takeji Y; Watanabe H; Tazaki J; Watanabe S; Saito N; Yamazaki K; Soga Y; Komiya T; Ando K; Minatoya K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Am J Cardiol; 2021 Mar; 142():35-43. PubMed ID: 33279479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
    Ito S; Watanabe H; Morimoto T; Yoshikawa Y; Shiomi H; Shizuta S; Ono K; Yamaji K; Soga Y; Hyodo M; Shirai S; Ando K; Horiuchi H; Kimura T
    Am J Cardiol; 2018 Jun; 121(11):1304-1314. PubMed ID: 29628128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Cohen DJ; Steg PG; Cannon CP; Apruzzese PK; D'Agostino RB; Massaro JM; Mauri L;
    JAMA Cardiol; 2017 May; 2(5):478-487. PubMed ID: 28297015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
    Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
    Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
    Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Yoshikawa Y; Tazaki J; Tada T; Watanabe H; Kato E; Toyofuku M; Inada T; Kaneda K; Takeda T; Sakai H; Yamamoto T; Eizawa H; Yamada M; Shinoda E; Mabuchi H; Shirotani M; Matsuda M; Takahashi M; Ishii K; Onodera T; Sakamoto H; Aoyama T; Miki S; Ando K; Kimura T;
    Am J Cardiol; 2022 Jan; 162():13-23. PubMed ID: 34706818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
    Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
    JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
    Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
    Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.
    Park J; Choi EK; Han KD; Kim B; Choi YJ; Lee SR; Kang J; Cha MJ; Park KW; Oh S; Lip GYH
    PLoS One; 2020; 15(10):e0240161. PubMed ID: 33057407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Park S; Ahn JM; Kim TO; Park H; Cho SC; Kang DY; Lee PH; Park DW; Park SJ;
    Am J Cardiol; 2020 Nov; 134():55-61. PubMed ID: 32891400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Yamamoto K; Shiomi H; Morimoto T; Takeji Y; Yoshikawa Y; Natsuaki M; Watanabe H; Tada T; Tazaki J; Yamaji K; Tamura T; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T
    Catheter Cardiovasc Interv; 2021 May; 97(6):E758-E770. PubMed ID: 33064372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Zheng K; Yoshida EM; Tacke F; Li Y; Guo X; Qi X
    J Clin Gastroenterol; 2020 Jan; 54(1):96-105. PubMed ID: 30882537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.